Delivery Order SPE2DB20D3103-SPE2DB25FP1V6
Award Date
6/16/25
Potential Completion Date
6/17/25
Potential Value
$32K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of TREMFYA 100 MG/ML ONE-PRESSML, a medical product, with a ceiling value of $15,405.74 and a performance period ending on June 12, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $13,125.47, is for the supply of TREMFYA 100 MG/ML ONE-PRESSML, a pharmaceutical product. The contract has an ultimate completion date of June 12, 2025 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This is a $8,493.51 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the provision of TREMFYA 100 MG/ML INJECTORML. The contract has an ultimate completion date of April 1, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,735.26, is for the delivery of the medication TREMFYA 100 MG/ML INJECTORML. It is a firm fixed-price delivery order contract with an ultimate completion date of April 30, 2025. The contract is not set aside and was awarded on April 29, 2025. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,368.63, is a delivery order for TREMFYA 100 MG/ML SYRINGEMG with a completion date of May 30, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the medical product TREMFYA 100 MG/ML ONE-PRESS, with a ceiling value of $25,539.19 and a performance period through June 11, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TREMFYA 100 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has a ceiling value of $33,757.80 and a period of performance through April 11, 2024. Amerisourcebergen Drug Corp is the prime contractor and has also been awarded an indefinite delivery contract (IDC) by DLA with a potential value of...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of the pharmaceutical product TREMFYA 100 MG/ML INJECTORML, with a ceiling value of $23,613.24 and a performance period through April 9, 2024. AmerisourceBergen Drug Corp serves as a prime contractor for DLA Troop Support Medical, providing a wide range of pharmaceutical and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the for-profit company AmerisourceBergen Corporation, to provide TREMFYA 100 MG/ML INJECTORML, a specialty pharmaceutical product, with a potential value of $10,767.95. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00, to deliver a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TREMFYA 100 MG/ML SYRINGE, with a ceiling value of $10,658.97 and a performance period extending through June 2025. The contract is not set aside, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...